Lv71
4540 积分 2022-11-02 加入
The race to reset autoimmune diseases
11天前
已完结
CD20 as a Target for Therapeutic Type I and II Monoclonal Antibodies
14天前
已完结
The immunopathogenesis of idiopathic nephrotic syndrome: a narrative review of the literature
23天前
已完结
Evidence supporting the use of anti-CD20 as first-line steroid-sparing agent in childhood nephrotic syndrome
1个月前
已完结
Comparison of biochemical response during antiviral treatment in patients with chronic hepatitis B infection
1个月前
已完结
HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues
1个月前
已完结
Tenofovir vs. entecavir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative resection
1个月前
已完结
Effects of first-line nucleot(s)ide analogues on lipid profiles in patients with chronic hepatitis B: a network meta-analysis
1个月前
已完结
Global burden of hepatitis B virus: current status, missed opportunities and a call for action
1个月前
已完结
Levamisole in childhood idiopathic nephrotic syndrome: new promises, and advocacy for global access
2个月前
已完结
皖公网安备34019202002308
